RecruitingNCT07438288

Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis

Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis - a Multicentre, Prospective, Observational Study From the SingHealth Chronic Liver Disease Registry (SoLiDaRity-DAM)


Sponsor

Singapore General Hospital

Enrollment

2,200 participants

Start Date

Aug 12, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients with liver cirrhosis. Clinical data will be retrieved from existing hospital records. This information may help doctors to identify patients with cirrhosis who are at risk of deterioration earlier (before they develop complications) and to develop effective treatment strategies to prevent or delay these complications. This study is designed as a prospective, non-interventional, observational study. This means that if you agree to participate in the study, you will not be required to undergo any additional hospital visits, tests, procedures or interventions other than the usual standard-of-care management that your doctor will provide. If you consent to participate in this study, you will be providing the study investigators permission to review and analyse your clinical data from the hospital clinical records. Your data will be collected throughout the course of your disease until liver transplantation or death.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients with clinical diagnosis of liver cirrhosis
  • Age 18 years and above (parental consent required if below 21 years)
  • Willing and able to provide informed consent

Exclusion Criteria2

  • No clinical evidence of liver cirrhosis
  • Not willing to provide informed consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERObservation

Patients with liver cirrhosis will be observed to monitor for death


Locations(3)

Changi General Hospital

Singapore, Singapore

Sengkang General Hospital

Singapore, Singapore

Singapore General Hospital

Singapore, Singapore

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07438288


Related Trials